SOPHIA ANTIPOLIS, France, September 12, 2011 — MEDIAN Technologies today announced the new finalization of its LMS applications portfolio installation at Hospital Universitari i Politècnic La Fe in Valencia, Spain.
This installation follows a sale performed as part of a local business action between MEDIAN Technologies and AGFA Healthcare Spain. On-site deployment of LMS solutions has been carried out through LMS solutions integration into AGFA Impax PACS (Picture Archiving and Communication System).
The new university hospital of La Fe is now one of the biggest public health structures in Spain and also the most recent one. Open to the public since February 2011, the hospital includes state-of-the- art medical equipment platforms, which LMS solutions are now part of.
MEDIAN LMS solutions will be used there in a clinical and translational research context as well as in radiologists’ daily practice, both for the follow-up of cancer patients, and for detection and follow-up of pulmonary lesions in other patients.
« We are very satisfied and proud of this success mainly for three reasons”, Gérard Milhiet, Executive Vice President and Co-founder of MEDIAN reports. “First, we are delighted to be chosen by Hospital La Fe, one of the most impressive medical imaging platforms of Spain. Then, our aim is to contribute with AGFA Healthcare Spain to good practices in pulmonary and oncologic imaging working with the medical team under the aegis of Pr. L. Marti-Bonmati. Finally, from a more technical point of view, we demonstrate once again the great capacity of our LMS clinical applications to be fully integrated into heterogeneous and multi-manufacturer environments”. “We intend to promote this prestigious reference among other health structures in Spain and beyond”, Gérard Milhiet concludes.
About LMS (Lesion Management Solutions): MEDIAN Lesion Management Solutions detect, evaluate and follow-up lesions identified in computed tomography (CT) scans. The LMS perform a number of measurements automatically (such as lesion dimensions, volume and density); these parameters are used in both routine clinical practice and during clinical trials to evaluate patient responses to cancer therapies.
LMS are adaptable and compatible with all CT scanners. They can be integrated into heterogeneous IT environments and easily installed on sites with very diverse equipment and software configurations.
MEDIAN LMS are provided as “Software as A Service"; they are web-based, fully distributed and available anywhere in the world.
About MEDIAN Technologies: MEDIAN Technologies was founded in 2002 by Fredrik Brag (the current Chairman and CEO), Gérard Milhiet and Arnaud Butzbach. It is based in Sophia-Antipolis (in the South of France) and has a subsidiary in the USA. The company currently has a staff of 40, over half of whom work in R&D.
MEDIAN Technologies offers solutions and services for diagnosing and monitoring cancer patients from medical images. It is targeting both the oncology clinical trials market (its prime market) and the patient care market. MEDIAN Technologies collaborates with institutes at the cutting edge of medical imaging, including the French National Institute for Computer Science and Control (INRIA), the Chicago University and the Swiss Federal Institute of Technology in Lausanne, Switzerland (EPFL).
MEDIAN Technologies has been present in the market since 2007 through direct sales of its Lesion Management Solutions and alliances with luminary cancer centers in Europe and the USA. For more information about MEDIAN, visit www.mediantechnologies.com
Press contacts
MEDIAN Technologies
Fredrik Brag, CEO
+33 4 92 90 65 82
fredrik.brag@mediantechnologies.com
ALIZE RP
Caroline Carmagnol
+ 33 6 64 18 99 59 // + 33 1 42 68 86 43
caroline@alizerp.com
Anne-Sophie Cosquéric
+ 33 1 42 68 86 41
Anne-sophie@alizerp.com
